ClinicalTrialsFinder

Localized Pancreatic Adenocarcinoma Clinical Trials in Maastricht

1 recruitingMaastricht, Netherlands

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

Borderline Resectable Pancreatic AdenocarcinomaResectable Pancreatic AdenocarcinomaLocalized Pancreatic Adenocarcinoma
Amsterdam UMC, location VUmc66 enrolled4 locationsNCT06384560